Bevacizumab in ovarian cancer: Clinical data and predictive and prognostic biomarkers.

Clin Transl Med · 2026 · PMC12789898 · PMID 41518057

Europe PMC DOI

hedged sentence

—

closest p

—

boldest claim

The sentences

did not reach statistical significanceno p-value reported

In the overall study population, the combination achieved a mPFS of 13.5 months compared with 11.3 months in the control arm, a difference that did not reach statistical significance.

also in 111,027 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.